GT Biopharma Inc (GTBP)

[kihmjc7]

After looking, my best guess on the institutional holding is it's mostly linked to Univ. of Minn. Not much else out there I've come across otherwise.


AUGUST 29, 2016
LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Oxis Biotech Inc., a wholly owned subsidiary of Oxis International Inc. (OTCQB: OXIS and Euronext Paris OXI.PA), announced today that its research partners at the University of Minnesota cancer center are collaborating with the National Institutes of Health to accelerate commercialization of their promising TriKE cancer-fighting platform.

The University of Minnesota is one of 14 high-impact research institutions across the country that are now in partnership with the NIH centers for commercialization (NCAI). The university was designated an NIH Research Evaluation and Commercialization Hub (REACH), a step that could boost efforts by Oxis and the university to commercialize new cancer therapies.

The University of Minnesota and Dr. Daniel A Vallera, Professor of Radiation Oncology at the University of Minnesota, were chosen for the award based on the TriKE platform because it's an improvement over current technology and because of its prospects for success based on efficacy studies.

Applications for the REACH award were invited from the areas of therapeutics, preventatives, diagnostics, devices, and tools.

In July, Oxis announced that it had agreed to a major partnership with the University of Minnesota to develop and commercialize cancer therapies using TriKE technology developed by researchers at the university.